Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

ZHOU Zheng, GUO Zhiying, TAN Hexin, Liu Jiaying, DIAO Yong, ZHANG Lei. Progress on germplasm resources of Baphicacanthus cusia(Nees) Bremek[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(1): 1-5,16. doi: 10.3969/j.issn.1006-0111.2017.01.001
Citation: ZHOU Zheng, GUO Zhiying, TAN Hexin, Liu Jiaying, DIAO Yong, ZHANG Lei. Progress on germplasm resources of Baphicacanthus cusia(Nees) Bremek[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(1): 1-5,16. doi: 10.3969/j.issn.1006-0111.2017.01.001

Progress on germplasm resources of Baphicacanthus cusia(Nees) Bremek

doi: 10.3969/j.issn.1006-0111.2017.01.001
  • Received Date: 2016-01-04
  • Rev Recd Date: 2016-06-20
  • Baphicacanthus cusia, widely distributed in the Southwest, Southern and Eastern regions of China, is an important medicinal plant of Acanthaceae family. Indigo made from stem and leaf of Baphicacanthus cusia in Fujian has the best quality in China, and is known as "Jian Indigo naturalis", which is the genuine medicinal of Fujian Province. The rhizoma of Baphicacanthus cusia could be used as medicine, called "Nanbanlangen", which together with indigo were included in the "Chinese Pharmacopoeia". Indigo and its original plant both contain indirubin, which has anti-cancer activity. Indirubin is an active ingredient of Huangdai Pian and Danggui Longhui Wan, two kinds of traditional Chinese medicine, which have been successfully used in the treatment of malignancies such as chronic myelogenous leukemia. The international advances in the biological characteristics, genetic diversity, cultivation technology and molecular biology of Baphicacanthus cusia germplasm resources were summarized. The main problems in Baphicacanthus cusia germplasm resources research are indicated, which could provide references for the further study and application of Baphicacanthus cusia germplasm resources.
  • [1] 黄以钟. 福建药用植物板蓝与建青黛的研究. 福州:福建农林大学,2009.
    [2] 王英, 沙飞,陈月华, 等. 靛玉红及其类似物抗肿瘤和神经保护作用的研究进展[J]. 中草药, 2014,45(16):2404-2411.
    [3] Nam S,Buettner R,Turkson J,et al.Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells[J].Proc Natl Acad Sci USA,2005,102(17):5998-6003.
    [4] Hoessel R, Leclerc S, Endicott JA, et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases[J]. Nat Cell Biol, 1999,1(1):60-67.
    [5] Vougogiannopoulou K, Skaltsounis AL. From Tyrian purple to kinase modulators:naturally halogenated indirubins and synthetic analogues[J]. Planta Med, 2012,78(14):1515-1528.
    [6] Wang L, Zhou GB, Liu P, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia[J]. Proc Natl Acad Sci USA, 2008,105(12):4826-4831.
    [7] 国家药典委员会. 中华人民共和国药典2015年版一部[S]. 北京:中国医药科技出版社, 2015:199.
    [8] 李园园, 方建国, 王文清, 等. 大青叶历史考证及现代研究进展[J]. 中草药, 2005,36(11):1750-1753.
    [9] 刘泽玉, 苏柘僮, 杨明, 等. 青黛炮制过程中靛蓝定向生成的工艺设计与优化[J]. 中草药, 2011, 42(1):56-60.
    [10] 李广华, 赵文法, 王蕴, 等. 药用青黛的质量考察[J]. 中国药事, 2009, 23(5):472-473.
    [11] 黄以钟, 潘大仁, 王占成, 等. 不同生长时期对马蓝药效成分的影响[J]. 中国农学通报, 2009, 25(16):75-78.
    [12] 黄璐琦, 戴住波, 吕冬梅, 等. 探讨道地药材研究的模式生物及模型[J]. 中国中药杂志, 2009, 34(9):1063-1066.
    [13] 胡世林. 中国道地药材原色图说[M]. 济南:山东科学技术出版社, 1998:86-87.
    [14] 普吴, 孙星衍, 孙冯翼. 神农本草经[M]. 北京:人民卫生出版社, 1984:25.
    [15] 李时珍. 本草纲目[M]. 北京:人民卫生出版社, 1985:1085-1086.
    [16] 胡嘉琪, 崔鸿宾, 张玉龙. 国产爵床科芦莉花族植物的花粉形态[J]. 植物分类学报, 2005, 43(2):123-150.
    [17] 中国科学院中国植物志编辑委员会. 中国植物志[M]. 北京:科学出版社, 2002:128-150.
    [18] 福建植物志编写组. 福建植物志[M]. 福州:科学出版社, 1989:132-133.
    [19] 李洪光. 药用植物马蓝和枳的遗传多样性分析研究[D]. 福州:福建农林大学, 2010.
    [20] 杨成梓, 刘小芬, 范世明. 药用植物马蓝的资源调查研究[J]. 中国现代中药, 2012, 14(3):33-35.
    [21] 朱仁磊. 福建马蓝资源化学及其水分生理学研究[D]. 福州:福建农林大学, 2011.
    [22] 张丹雁, 林秀旎, 陈晓庆, 等. 南板蓝(马蓝)驯育栽培技术研究[J]. 现代中药研究与实践, 2010, 24(2):18-19.
    [23] 张旭, 何明辉, 魏成熙. 贵州省道地药材南板蓝根引种栽培研究[J]. 安徽农业科学, 2010, 38(33):18730-18731.
    [24] 杜沛欣. 马蓝GAP规范化种植研究进展[J]. 海峡药学, 2011, 23(8):57-59.
    [25] 张英娇, 魏道智, 宁书菊, 等. 氮磷钾对马蓝营养生长与叶片有效成分含量的影响[J]. 中国中药杂志, 2009, 34(10):1299-1301.
    [26] 魏世勇, 张旭, 魏成熙. 南板蓝的营养特性及栽培技术[J]. 山地农业生物学报, 2003, 22(6):493-498.
    [27] 陈瑞芳, 刘颖嘉, 程习梅, 等. 马蓝光合特性研究[J]. 福建农林大学学报(自然科学版), 2014, 43(3):225-229.
    [28] 宁书菊, 张英娇, 林建勇, 等. 光强对福建马蓝光合特性的影响[J]. 中国生态农业学报, 2012, 20(7):901-908.
    [29] 覃军, 陈奕龙, 张丹雁, 等. 不同光照条件对南大青叶(马蓝叶)中靛玉红含量的影响[J]. 安徽农业科学, 2014, 42(1):59-60.
    [30] 魏道智, 林文雄, 陈慧, 等. 福建马蓝的种苗繁殖与栽培[C].第六届全国药用植物和植物药学术研讨会论文集.长春,2006, 127-129.
    [31] 崔红艳, 方子森, 牛俊义. 胡麻栽培技术的研究进展[J]. 中国农学通报, 2014, 30(18):8-13.
    [32] 龙菊生, 聂垚. 林下套种马蓝(山蓝)技术[J]. 现代园艺, 2013,(3):28.
    [33] 蔡益航, 吴建宇. 枇杷园套种青黛高产栽培技术[J]. 现代农业科技, 2013,(19):103-105.
    [34] 张丽梅, 陈菁瑛, 陈熹. 马蓝未成熟种子的组织培养[J]. 植物生理学通讯, 2007, 43(3):521.
    [35] 孙云玲, 姚洪源, 田华林, 等. 马蓝组培快繁技术研究[J]. 现代农业科技, 2010,(9):102-103.
    [36] 朱永宏, 李学敏, 韩宝玲. RAPD技术在中药材鉴定中的应用进展[J]. 中草药, 2007, 38(9):1443-1444.
    [37] 黄玉吉, 陈菁瑛. 马蓝种质资源的RAPD分析[J]. 中药材, 2010, 33(2):183-186.
    [38] 于英君, 肖井仁, 姜颖, 等. 菘蓝和马蓝基因组DNA RAPD指纹图谱的建立[J]. 中医药学报, 2013, 41(6):26-27.
    [39] 向小亮, 宁书菊, 黄延龄, 等. 外源水杨酸对马蓝叶片中蛋白水平表达的影响[J]. 应用生态学报, 2010, 21(3):689-693.
    [40] 龚小贵. 不同浓度茉莉酸甲酯对马蓝生理与蛋白质的影响[D]. 福州:福建农林大学, 2011.
    [41] Marcinek H, Weyler W, Deus-Neumann B, et al. Indoxyl-UDPG-glucosyltransferase from Baphicacanthus cusia[J]. Phytochemistry, 2000,53(2):201-207.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(3741) PDF downloads(1865) Cited by()

Related
Proportional views

Progress on germplasm resources of Baphicacanthus cusia(Nees) Bremek

doi: 10.3969/j.issn.1006-0111.2017.01.001

Abstract: Baphicacanthus cusia, widely distributed in the Southwest, Southern and Eastern regions of China, is an important medicinal plant of Acanthaceae family. Indigo made from stem and leaf of Baphicacanthus cusia in Fujian has the best quality in China, and is known as "Jian Indigo naturalis", which is the genuine medicinal of Fujian Province. The rhizoma of Baphicacanthus cusia could be used as medicine, called "Nanbanlangen", which together with indigo were included in the "Chinese Pharmacopoeia". Indigo and its original plant both contain indirubin, which has anti-cancer activity. Indirubin is an active ingredient of Huangdai Pian and Danggui Longhui Wan, two kinds of traditional Chinese medicine, which have been successfully used in the treatment of malignancies such as chronic myelogenous leukemia. The international advances in the biological characteristics, genetic diversity, cultivation technology and molecular biology of Baphicacanthus cusia germplasm resources were summarized. The main problems in Baphicacanthus cusia germplasm resources research are indicated, which could provide references for the further study and application of Baphicacanthus cusia germplasm resources.

ZHOU Zheng, GUO Zhiying, TAN Hexin, Liu Jiaying, DIAO Yong, ZHANG Lei. Progress on germplasm resources of Baphicacanthus cusia(Nees) Bremek[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(1): 1-5,16. doi: 10.3969/j.issn.1006-0111.2017.01.001
Citation: ZHOU Zheng, GUO Zhiying, TAN Hexin, Liu Jiaying, DIAO Yong, ZHANG Lei. Progress on germplasm resources of Baphicacanthus cusia(Nees) Bremek[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(1): 1-5,16. doi: 10.3969/j.issn.1006-0111.2017.01.001
Reference (41)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return